Text size Maddie Meyer / Getty Images Moderna on Thursday lost a patent case that had been almost entirely overlooked as the stock increased due to excitement over the company’s Covid-19 vaccine, which will be tested in a large Phase 3 trial to begin. next week. What the decision issued …
Read More »AstraZeneca Covid-19 data looks positive, but falls short of last week’s hype
Text size Jason Alden / Bloomberg Data on the Covid-19 vaccine in development by AstraZeneca and the University of Oxford published in The Lancet on Monday looked positive, but the stock fell after rising last week due to high expectations for the data. Shares of the US deposit receipt for …
Read More »Race for a Covid-19 vaccine could have political side effects
As the Covid-19 crisis intensifies in the United States, the fight for an effective vaccine is about to collide with the electoral calendar. Pfizer (ticker: PFE) says it will seek authorization from the Food and Drug Administration for its Covid-19 vaccine starting in October. Meanwhile, the federal government’s Covid-19 vaccine …
Read More »News updates: Walmart will require all shoppers to wear skins
At the Roosevelt Field Mall in Garden City, New York, a sign is displayed requiring customers to wear masks when entering the store. Photo by Al Bello / Getty Images Text size Here’s what you need to know about the impact of Covid-19 to navigate the markets today. • Oklahoma …
Read More »Here is the facts about the Moderna vaccine test. So far so good.
Text size Moderna’s headquarters in Cambridge, Massachusetts. Joseph Prezioso / AFP / Getty Images Moderna’s announcement of positive data about a Phase 1 trial of its Covid-19 vaccine in May was met with skepticism by some experts, who noted that the company had not included many details about the trial’s …
Read More »